DUBLIN–(BUSINESS WIRE)–The “Preclinical Contract Research Organizations – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Global Preclinical Contract Research Organizations Market to Reach $6.9 Billion by 2027
Amid the COVID-19 crisis, the global market for Preclinical Contract Research Organizations estimated at US$ 4.3 Billion in the year 2020, is projected to reach a revised size of US$ 6.9 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027.
Toxicology Testing, one of the segments analyzed in the report, is projected to record a 6.7% CAGR and reach US$ 4.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bioanalysis & DMPK Studies segment is readjusted to a revised 7.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 6.4% CAGR
The Preclinical Contract Research Organizations market in the U.S. is estimated at US$ 1.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$ 1.2 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 5.6% respectively over the 2020-2027 period. Within Europe, Germany is…
